tiprankstipranks
Trending News
More News >
Strides Pharma Science Ltd (IN:STAR)
:STAR
India Market

Strides Pharma Science Ltd (STAR) Ratios

Compare
3 Followers

Strides Pharma Science Ltd Ratios

IN:STAR's free cash flow for Q2 2026 was ₹0.35. For the 2026 fiscal year, IN:STAR's free cash flow was decreased by ₹ and operating cash flow was ₹0.16. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.15 1.20 1.03 1.08 0.99
Quick Ratio
0.64 0.70 0.64 0.70 0.64
Cash Ratio
0.05 0.05 0.06 0.10 0.05
Solvency Ratio
0.19 1.09 0.04 <0.01 -0.05
Operating Cash Flow Ratio
0.14 0.26 0.24 0.01 -0.08
Short-Term Operating Cash Flow Coverage
0.30 0.56 0.40 0.03 -0.13
Net Current Asset Value
₹ -4.05B₹ -3.63B₹ -7.99B₹ -12.22B₹ -12.28B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.31 0.43 0.46 0.43
Debt-to-Equity Ratio
0.67 0.74 1.18 1.37 1.28
Debt-to-Capital Ratio
0.40 0.42 0.54 0.58 0.56
Long-Term Debt-to-Capital Ratio
0.15 0.18 0.24 0.34 0.26
Financial Leverage Ratio
2.37 2.37 2.75 3.00 2.96
Debt Service Coverage Ratio
0.64 0.53 0.20 0.29 0.02
Interest Coverage Ratio
3.77 7.16 0.96 0.47 -1.43
Debt to Market Cap
0.22 0.29 0.69 2.24 1.87
Interest Debt Per Share
220.39 231.30 311.13 365.31 356.74
Net Debt to EBITDA
1.64 2.02 5.36 5.42 -21.21
Profitability Margins
Gross Profit Margin
36.00%57.18%22.23%21.95%47.44%
EBIT Margin
17.49%14.47%5.73%7.09%-11.89%
EBITDA Margin
21.94%18.63%11.48%13.71%-4.38%
Operating Profit Margin
14.93%38.52%7.88%3.37%-8.21%
Pretax Profit Margin
13.27%10.53%-3.00%-7.80%-21.25%
Net Profit Margin
10.82%77.71%-1.84%-6.03%-14.99%
Continuous Operations Profit Margin
11.23%8.85%-3.76%-6.29%-15.45%
Net Income Per EBT
81.57%738.00%61.51%77.29%70.53%
EBT Per EBIT
88.88%27.33%-38.03%-231.54%258.99%
Return on Assets (ROA)
7.84%59.41%-1.21%-3.33%-6.60%
Return on Equity (ROE)
20.24%140.82%-3.32%-10.00%-19.51%
Return on Capital Employed (ROCE)
19.43%51.53%10.20%3.39%-7.07%
Return on Invested Capital (ROIC)
12.14%31.77%6.38%1.87%-3.29%
Return on Tangible Assets
9.70%72.83%-1.48%-3.98%-7.85%
Earnings Yield
6.14%58.57%-2.01%-17.87%-30.82%
Efficiency Ratios
Receivables Turnover
4.13 3.84 3.35 2.60 1.70
Payables Turnover
2.54 1.92 3.50 2.91 1.51
Inventory Turnover
2.07 1.55 2.64 2.50 1.37
Fixed Asset Turnover
4.52 4.72 3.92 2.67 2.03
Asset Turnover
0.72 0.76 0.66 0.55 0.44
Working Capital Turnover Ratio
22.35 15.49 22.33 35.63 179.56
Cash Conversion Cycle
121.03 140.13 142.54 161.12 237.71
Days of Sales Outstanding
88.34 94.95 108.87 140.19 214.57
Days of Inventory Outstanding
176.15 235.52 138.07 146.17 265.51
Days of Payables Outstanding
143.47 190.34 104.40 125.24 242.38
Operating Cycle
264.50 330.47 246.94 286.35 480.09
Cash Flow Ratios
Operating Cash Flow Per Share
42.48 74.37 77.04 4.93 -28.73
Free Cash Flow Per Share
26.29 48.02 64.06 -5.61 -44.70
CapEx Per Share
16.19 26.35 12.98 10.54 15.98
Free Cash Flow to Operating Cash Flow
0.62 0.65 0.83 -1.14 1.56
Dividend Paid and CapEx Coverage Ratio
2.10 2.58 5.32 0.47 -1.55
Capital Expenditure Coverage Ratio
2.62 2.82 5.93 0.47 -1.80
Operating Cash Flow Coverage Ratio
0.21 0.36 0.28 0.01 -0.09
Operating Cash Flow to Sales Ratio
0.08 0.15 0.18 0.01 -0.08
Free Cash Flow Yield
2.91%7.20%16.61%-4.08%-26.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.17 1.71 -49.69 -5.60 -3.24
Price-to-Sales (P/S) Ratio
1.75 1.33 0.92 0.34 0.49
Price-to-Book (P/B) Ratio
3.00 2.40 1.65 0.56 0.63
Price-to-Free Cash Flow (P/FCF) Ratio
34.15 13.89 6.02 -24.50 -3.72
Price-to-Operating Cash Flow Ratio
21.13 8.97 5.00 27.88 -5.79
Price-to-Earnings Growth (PEG) Ratio
0.56 >-0.01 0.73 0.11 0.01
Price-to-Fair Value
3.00 2.40 1.65 0.56 0.63
Enterprise Value Multiple
9.62 9.14 13.35 7.89 -32.31
Enterprise Value
100.30B 78.78B 58.65B 39.64B 43.47B
EV to EBITDA
9.67 9.14 13.35 7.89 -32.31
EV to Sales
2.12 1.70 1.53 1.08 1.42
EV to Free Cash Flow
41.40 17.83 10.06 -78.46 -10.84
EV to Operating Cash Flow
25.62 11.51 8.37 89.26 -16.86
Tangible Book Value Per Share
168.92 159.95 111.56 121.67 141.78
Shareholders’ Equity Per Share
299.03 277.31 233.57 245.59 262.87
Tax and Other Ratios
Effective Tax Rate
0.15 0.16 -0.25 0.19 0.27
Revenue Per Share
512.76 502.49 420.67 407.20 342.10
Net Income Per Share
55.50 390.50 -7.76 -24.56 -51.28
Tax Burden
0.82 7.38 0.62 0.77 0.71
Interest Burden
0.76 0.73 -0.52 -1.10 1.79
Research & Development to Revenue
0.02 0.00 0.00 0.02 0.03
SG&A to Revenue
0.05 0.19 0.04 0.20 0.05
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 >-0.01
Income Quality
0.79 1.69 -11.18 -0.17 0.40
Currency in INR